Inhibition of metastatic liver tumor with intravascular IL-12 gene therapy

Mei-lan JIN,Qing-gao ZHANG,Dan JIN,Hong-hua LI,Fang-fang LI,Quan-xin JIN,Hong BAO,Feng-de CUI

DOI: https://doi.org/10.16068/j.1000-1824.2010.04.022

2010-01-01

Abstract:OBJECTIVE To explore the treatment and the suppression of hepatic metastases efficacy of intravascular administration of plasmid DNA expressing mIL-12.METHODSTo establish tumor models,the M5076 cells were injected into peritoneal cavity or inoculated into the footpad of mice.The hydrodynamics-based transfection was perfomed for transfer pGEG.mIL-12 into C57BL/6 mice.The different survival rate and the number of matastatic foci were observed in experimental and control group animals.The expression of IL-12 and IFN-γ were assayed by ELISA.The activity of NK cells and lymphocyte proliferation from the spleen cells were measured by 51Cr release assay.RESULTSCompared with mice treated with saline or untreated,the significant elevation of the serum concentration of IL-12 and IFN-γ were detected in mice treated with pGEG.mIL-12.The pGEG.mIL-12 transfection drastically suppressed the subcutaneous as well as hepatic metastatic tumors,resulting in significant prolongation of survival period of the animals.Growth of tumor in treated with pGEG.mIL-12 group was significantly inhibited as compared with that in other groups.Transfection with pGEG.mIL-12 also suppressed peritoneal carcinomatosis and prolonged survival time in mice that had been injected with M5076 cells into the peritoneal cavity.The M5076 cells were resistant to CTL and NK cell cytotoxicity.CONCLUSIONThe high level of IL-12 production elicited by the hydrodynamics-based trasfection of the cytokine gene may be quite effective in inhibiting matastatic and CTL-unsusceptible tumor cells.